North America Proteomics Market Size, Growth, Share & Trends Analysis
North America Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The North America proteomics market is projected to grow from USD 14.11 billion in 2025 to USD 25.62 billion by 2030, at a CAGR of 12.7% from 2025 to 2030, supported by rapid advances in mass spectrometry, bioinformatics, and high-throughput sample-processing platforms. Proteomics focuses on measuring dynamic protein expression, modifications, and interactions at scale, enabling deeper insights into disease biology and treatment response across oncology, neurology, and other complex indications.
KEY TAKEAWAYS
-
BY COUNTRYThe US proteomics market was the fastest growing market with 13% CAGR during the forecast period
-
BY INTRUMENTATIONBy product, the spectroscopy segment is expected to dominate the market.
-
BY REAGENTBy reagent, the immunoassay reagent segment is projected to grow at the fastest rate from 2025 to 2030.
-
BY SERVICEBy service, core proteomics services dominate the North American proteomics market.
-
BY SOFTWAREBy Software, the bioinformatics tools segment is expected to dominate the market.
-
BY APPLICATIONBy application, the clinical diagnostics segment will grow the fastest during the forecast period.
-
BY END USERBy end user, the biopharmaceutical companies segment is expected to dominate the market.
-
COMPETITIVE LANDSCAPEThermo Fisher Scientific Inc. (US), Danaher Corporation (US), and Agilent Technologies (US) were identified as key players in the North American proteomics market, given their strong market share and product portfolios.
-
COMPETITIVE LANDSCAPESeer Inc. (US), Alamar Biosciences Inc (US), among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The North America proteomics market is expanding steadily, supported by strong research funding, active public-private programs, and increasing use of proteomics in clinical decision-making. Advanced proteomics platforms help researchers and clinicians better understand disease biology, identify new drug targets, and develop more precise treatments.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The North America proteomics market is being reshaped by fast-moving scientific, regulatory, and clinical trends, and these shifts are expected to deepen over the forecast period. The growing use of proteomics in precision oncology, cardiology, and other complex diseases, together with strong momentum in clinical trials, is driving demand for high-throughput, reliable platforms in hospitals and research centers.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Growing clinical proteomics momentum
-
Strong funding & public-private programs
Level
-
Data complexity & standardization gaps
Level
-
Integrated multi-omics solutions for drug discovery and translational research.
Level
-
Data privacy & sharing hurdles
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing clinical proteomics momentum
North America is seeing strong momentum in clinical proteomics as hospitals, reference labs, and academic medical centers expand programs in biomarker discovery, precision oncology, and personalized medicine. This shift from research-only use to routine clinical decision support is accelerating demand for high-throughput mass spectrometry platforms, robust sample-prep workflows, and advanced data-analysis tools across the region.
Restraint: Data complexity & standardization gaps
Highly complex datasets, fragmented workflows, and non-uniform reporting standards make result comparison across sites very difficult, thereby slowing clinical translation for North American proteomics labs.
Opportunity: Integrated multi-omics solutions for drug discovery and translational research.
Web-based integrated multi-omics solutions for drug discovery and translational research integrate proteomics with genomics, metabolomics, and clinical data, providing deeper insights into disease biology and helping identify new drug targets in North American pharma and academic centers, thereby improving the translation of biomarkers into more precise therapies.
Challenge: Data privacy & sharing hurdles
Patient-linked proteomics and multi-omics datasets raise considerable concerns about consent, privacy, and secure data transfer. Consequently, it is difficult for institutions to share information across borders or on cloud platforms while complying with HIPAA and other regulations.
NORTH AMERICA PROTEOMICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides Orbitrap-based mass spectrometers, LC-MS workflows, and Olink next-generation proteomics platforms used for large-scale biomarker discovery, clinical proteomics assays, and multi-omics studies at leading North American pharma companies, CROs, and academic medical centers | Improves depth and throughput of protein profiling, supports robust biomarker validation for precision-medicine trials, and helps customers generate high-quality, regulatory-ready data for translational and clinical research programs |
 |
Through SCIEX and Cytiva, Danaher supplies high-resolution LC-MS/MS systems, sample-prep workflows, and bioprocessing tools that support quantitative proteomics, protein characterization, and biotherapeutic development in North American pharma, biotech, and core facilities | Delivers sensitive, reproducible protein quantification and structural insight, helping customers accelerate biomarker discovery, optimize biologics development, and generate robust data packages for regulatory submissions |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The North America proteomics market is closely interconnected among instrument companies, bioinformatics companies, CROs, biopharma, and clinical labs. Companies provide high-throughput instrumentation and analytical solutions, and CROs and core labs conduct research-oriented studies. Thus, they assist hospitals and biopharma companies in quickly identifying biomarkers with high-quality results and in advancing the reality of precision medicine using proteomics.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
North america proteomics Market, By instrumentation technology.
In 2024, the spectroscopy-based platforms segment commanded the largest share of the North American proteomics market as high-resolution MS systems remain the backbone for deep protein identification and quantification in research and clinical labs.
north america proteomics Market, By Reagent
In 2024, immunoassay reagents accounted for the highest share, owing to increasing demand for targeted protein panels and high-throughput biomarker validation in drug development and clinical studies.
north america proteomics Market, By service
Core proteomics services dominate the market. Many pharma companies, biotechs, and hospitals outsource complex LC-MS and multi-omics workflows to specialized CROs or core facilities to generate faster, high-quality data.
north america proteomics Market, By software
In 2024, bioinformatics tools, by software, accounted for the largest share because advanced data-analysis, visualization, and integration platforms have become vital for making sense of large, complex proteomics datasets and connecting them to genomic and clinical information.
north america proteomics Market, By application
By application, clinical diagnostics is expected to see the fastest growth, as hospitals and reference labs increasingly look to proteomic signatures for early disease detection, treatment selection, and monitoring in oncology and other chronic conditions.
north america proteomics Market, By End User
Biopharmaceutical companies were the leading end-user group in 2024, because of the heavy investment therein in target discovery, lead optimization, and biomarker-based clinical trial stratification within the domain of both biologics and advanced therapies.
REGION
US to be fastest-growing region in market during forecast period
During the forecast period, the US remained among the fastest-growing markets for manufacturing-scale pharmaceutical filtration, driven by the continued expansion of commercial biologics and vaccine production capacity. Strong pipelines in monoclonal antibodies, biosimilars, and advanced modalities, coupled with substantial investment in large CDMO campuses and facility upgrades by major pharma companies, are accelerating adoption of high-performance filtration trains across new and existing plants.
NORTH AMERICA PROTEOMICS MARKET: COMPANY EVALUATION MATRIX
In the North America proteomics market matrix, Thermo Fisher Scientific (Star Player) has widely adopted mass spectrometry platforms, proteomics panels, and software that anchor major pharma, CRO, and academic workflows. Bio-Rad Laboratories (emerging leader) is gaining share with its protein separation and multiplex immunoassay solutions that support targeted and translational proteomics. Smaller specialist proteomics and multi-omics firms focused on niche applications and agile services add further competitive momentum and are well positioned to move into the leaders’ quadrant over time.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- THERMOFISHER SCIENTIFIC INC (US)
- DANAHER CORPORATION (US)
- AGILENT TECHNOLOGIES (US)
- BIO-RAD LABORATORIES (US)
- REVVITY (US)
- ILLUMINA INC. (US)
- PROMEGA CORPORATION (US)
- SEER INC (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 13.06 Billion |
| Market Forecast in 2030 (Value) | USD 25.62 Billion |
| Growth Rate | CAGR of 12.7 % from 2025-2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Million) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Countries Covered | US & Canada |
WHAT IS IN IT FOR YOU: NORTH AMERICA PROTEOMICS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Proteomics technology insights (North America) | Mapped leading platforms and vendors by use case (discovery, translational, clinical), assessed cloud and on-premises data-analysis options, and benchmarked performance, scalability, and regulatory readiness across key US and Canadian research and hospital network | Helps instrument and service providers tune product portfolios and go-to-market strategies to the needs of pharma, CROs, and clinical labs, supporting better positioning in high-value North American biomarker and precision-medicine programs. |
| Innovation & multi-omics R&D trends (North America) | Profiled key innovation clusters, flagship cohort studies, and technology pilots in major cancer centers and academic medical hubs, highlighting where new platforms and workflows are being adopted first and how they are likely to diffuse into routine translational and clinical use. | Guides R&D, partnership, and investment decisions by pinpointing high-growth niches in clinical proteomics and multi-omics, helping vendors and investors prioritize collaborations and product roadmaps that align with the next wave of precision-medicine demand in North America. |
RECENT DEVELOPMENTS
- October 2023 : Thermo Fisher Scientific accuired Olink Holding AB of Sweden, strengthening its position in the rapidly expanding proteomics space. The deal is intended to speed up protein biomarker discovery and create meaningful synergies between Thermo Fisher’s analytical platforms and Olink’s targeted proteomics technologies
- June 2024 : Danaher entered into a collaboration with Spain-based Mass Analytica to launch AI Quant, an artificial-intelligence-driven quantitation software that supports high-resolution MS/MS workflows using an intelligent fragment-selection algorithm.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This study involved four major activities in estimating the current size of the north america proteomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and other approaches were employed to estimate the complete market size (north america proteomics market size). After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the north america proteomics market. The secondary sources referred to for this research study include publications from government and private sources such as the Indian Pharmaceutical Association (IPA), the Pharmaceutical Research and Manufacturers of America (PhRMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), Central Drugs Standard Control Organization (CDSCO), Indian Brand Equity Foundation (IBEF), European Medicines Agency (EMA), Global Cancer Observatory (GCO), American Chemical Society (ACS), National Center for Biotechnology Information (NCBI), Food and Drug Administration (FDA), Biotechnology and Biological Sciences Research Council (BBSRC), Pharmaceutical Research and Manufacturers of America (PhRMA), and the World Journal of Pharmaceutical Sciences, Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the north america proteomics market, which was then validated by primary research.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
Europe Proteomics Market Size Estimation
A top-down approach was used to estimate and validate the total size of the north america proteomics market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the total north america proteomics market size includes the following:
Data Triangulation
After arriving at the overall north america proteomics market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Proteomics is the complete evaluation of the structure and function of proteins to understand an organism’s nature. It is the systemic identification and characterization of proteins along with their sequence, abundance, post-translational modifications, interactions, activity, subcellular localization, and structure. The market study includes the assessment of various instruments, reagents, software, and services used in north america proteomics.
Key Stakeholders
- Life sciences instrumentation and reagent companies
- Pharmaceutical and biotechnology companies
- Proteomics database and software providers
- Proteomics service providers
- Research and consulting firms
- Academic medical centers
- Government research organizations
- Clinical research institutes
- Contract Research Organizations
Report Objectives
- To define, describe, and forecast the proteomics market based on the instrumentation technologies, reagents, software & services, application, end-user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall proteomics market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
- To strategically profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
- To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, collaborations, and R&D activities in the proteomics market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Geographic Analysis
- Further breakdown of the Rest of Europe proteomics market into respective countries
- Further breakdown of the Rest of Asia Pacific proteomics market into respective countries
- Further breakdown of the Rest of Latin America proteomics market into respective countries
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
- An additional five company profiles
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the North America Proteomics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in North America Proteomics Market